Fundraising FoxPropel Bio Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Persephone Biosciencespersephone.bioinFeb 2021✓ verified
Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development.
BiotechConsumerDigital HealthFemTechHealthtechSan Diego, US
Stephen Van Dien(Founder)inStephanie Culler(Founder)in
Co-investorsFirst Bight VenturesBioBritFifty YearsHemi Ventures, LlcOcampo CapitalPioneer+13 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.